Targeting histone deacetylases as an approach to treat neonatal asphyxia.

2015/17/N/NZ7/00969

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • NZ7_12: Prewencja chorób człowieka

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Joanna Jaworska

Number of co-investigators in the project: 2

Call

PRELUDIUM 9 – announced on 2015-03-16

Amount awarded
99 960 PLN
Project start date
2016-01-21
Project end date
2018-01-20
Project duration
24 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (3)

  1. Effect of the HDAC Inhibitor, Sodium Butyrate, on Neurogenesis in a Rat Model of Neonatal Hypoxia–Ischemia: Potential Mechanism of Action

    Authors:
    Joanna Jaworska, Teresa Zalewska, Joanna Sypecka, Malgorzata Ziemka-Nalecz
    Academic press:
    Molecular Neurobiology (year: 2019, volume: brak, pages: brak), Publisher: Springer US
    Status:
    Published
    DOI:
    10.1007/s12035-019-1518-1 – link to the publication
  2. Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia

    Authors:
    Ziemka-Nalecz M, Jaworska J, Zalewska T
    Academic press:
    Journal of Neuropathology & Experimental Neurology (year: 2017, volume: 76, pages: 644–654), Publisher: Oxford Academic
    Status:
    Published
    DOI:
    10.1093/jnen/nlx046 – link to the publication
  3. The potential neuroprotective role of a histone deacetylase inhibitor, Sodium Butyrate, after neonatal hypoxia-ischemia

    Authors:
    Joanna Jaworska, Malgorzata Ziemka-Nalecz, Joanna Sypecka, Teresa Zalewska
    Academic press:
    Journal of Neuroinflammation (year: 2017, volume: 14, pages: brak), Publisher: BioMed Central
    Status:
    Published
    DOI:
    10.1186/s12974-017-0807-8 – link to the publication

Articles in post-conference publications (2)

  1. A histone deacetylase inhibitor, Sodium Butyrate, prevents an inflammatory response associated with neonatal hypoxia-ischemia

    Authors:
    Jaworska J., Ziemka-Nalecz M., Zalewska T.
    Conference:
    Joint Conference: The 13th International Symposium Molecular basis of pathology and therapy in neurological disorders and The 4th International Conference Stem cells: therapeutic outlook for central nervous system disorders (year: 2016, pages: 334-335), Publisher: Folia Neuropathologica
    Date:
    conference 17-18.11
    Status:
    Published
  2. Beneficial role of MMPs in neurogenesis after Sodium Butyrate treatment in a model of neonatal hypoxia-ischemia

    Authors:
    Ziemka-Nalecz M., Gajos M., Jaworska J., Sypecka J., Zalewska T.
    Conference:
    Joint Conference: The 13th International Symposium Molecular basis of pathology and therapy in neurological disorders and The 4th International Conference Stem cells: therapeutic outlook for central nervous system disorders (year: 2016, pages: 350-351), Publisher: Folia Neuropathologica
    Date:
    conference 17-18.11
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski